This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
HHS Secretary Robert F. Kennedy won’t be appearing before a Senate panel on Thur...
As President Donald Trump’s tariffs roil financial markets, biopharma is no exce...
As President Donald Trump’s tariffs roil financial markets, biopharma is no exce...
RayThera has collected $110 million in a Series A raise to help it advance a pre...
Plus, news about Kashiv BioSciences: Lexeo Therapeutics reveals early data f...
Multi-partnered ADC startup Duality Biologics is moving forward with its initial...
Rhythm Pharmaceuticals is looking to expand the potential market for its rare ob...
Another CDMO has been hit by the slowdown of cell and gene therapy R&D. Ampl...
South Korean biotech ABL Bio has lined up another platform license agreement wit...
Gene editing pioneer David Liu was awarded one of three Breakthrough Prizes in L...
Medicines based on glucagon-like peptide-1 (GLP-1) have revolutionized the treat...
Welcome back to Endpoints Weekly! Much of this week’s headlines dealt with the f...
The Trump administration finalized new policies for some Medicare programs on Fr...
GSK and Pfizer have settled a lawsuit alleging Pfizer’s RSV shot Abrysvo infring...
Ousted FDA biologics and vaccine chief Peter Marks was asked to provide non-exis...
On the precipice of FDA approval, Novavax's Covid vaccine is now in limbo while ...